Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:INFU NASDAQ:INGN NYSEAMERICAN:MYO NYSEAMERICAN:STXS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINFUInfuSystem$9.15+0.8%$9.44$5.38▼$11.04$184.67M1.43149,609 shs78,430 shsINGNInogen$6.76+3.4%$6.61$5.34▼$9.13$177.07M1.6333,081 shs211,311 shsMYOMyomo$1.18-0.8%$1.02$0.61▼$2.38$45.98M1.471.23 million shs760,467 shsSTXSStereotaxis$1.63-6.9%$1.89$1.61▼$3.59$171.04M1.35363,103 shs833,968 shs10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINFUInfuSystem+0.77%+4.57%-5.28%-5.67%+46.17%INGNInogen+3.36%+6.12%+5.62%+4.00%-4.11%MYOMyomo-0.84%-16.90%+13.46%+73.27%-50.00%STXSStereotaxis-6.86%-8.43%-15.10%-13.76%-25.23%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINFUInfuSystem$9.15+0.8%$9.44$5.38▼$11.04$184.67M1.43149,609 shs78,430 shsINGNInogen$6.76+3.4%$6.61$5.34▼$9.13$177.07M1.6333,081 shs211,311 shsMYOMyomo$1.18-0.8%$1.02$0.61▼$2.38$45.98M1.471.23 million shs760,467 shsSTXSStereotaxis$1.63-6.9%$1.89$1.61▼$3.59$171.04M1.35363,103 shs833,968 shs10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINFUInfuSystem+0.77%+4.57%-5.28%-5.67%+46.17%INGNInogen+3.36%+6.12%+5.62%+4.00%-4.11%MYOMyomo-0.84%-16.90%+13.46%+73.27%-50.00%STXSStereotaxis-6.86%-8.43%-15.10%-13.76%-25.23%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINFUInfuSystem 2.67Moderate Buy$15.0063.93% UpsideINGNInogen 2.50Moderate BuyN/AN/AMYOMyomo 3.00Buy$7.50535.59% UpsideSTXSStereotaxis 3.00Buy$3.88137.73% UpsideCurrent Analyst Ratings BreakdownLatest MYO, INFU, INGN, and STXS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/8/2026MYOMyomo Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$9.50 ➝ $10.006/3/2026STXSStereotaxis CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingMarket Outperform5/13/2026STXSStereotaxis Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$4.00 ➝ $3.505/8/2026INGNInogen Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/7/2026INGNInogen Freedom CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy(Data available from 6/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINFUInfuSystem$142.40M1.30$0.72 per share12.79$2.47 per share3.70INGNInogen$348.67M0.53N/AN/A$7.08 per share0.95MYOMyomo$40.93M1.11N/AN/A$0.30 per share3.93STXSStereotaxis$32.38M4.92N/AN/A$0.14 per share11.64Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINFUInfuSystem$870K$0.38152.5329.52N/A1.12%2.78%1.41%N/AINGNInogen-$22.75M-$0.91N/AN/AN/A-7.08%-12.90%-8.27%8/6/2026 (Estimated)MYOMyomo-$15.57M-$0.23N/AN/AN/A-36.69%-119.60%-42.50%8/10/2026 (Estimated)STXSStereotaxis-$21.64M-$0.28N/AN/AN/A-69.50%-163.30%-30.08%8/6/2026 (Estimated)Latest MYO, INFU, INGN, and STXS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026INGNInogen-$0.24-$0.30-$0.06-$0.30$82.35 million$85.11 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthINFUInfuSystemN/AN/AN/AN/AN/AINGNInogenN/AN/AN/AN/AN/AMYOMyomoN/AN/AN/AN/AN/ASTXSStereotaxisN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINFUInfuSystem0.501.981.59INGNInogenN/A3.102.70MYOMyomo1.212.732.36STXSStereotaxisN/A1.561.11Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINFUInfuSystem71.13%INGNInogen89.94%MYOMyomo44.99%STXSStereotaxis45.35%Insider OwnershipCompanyInsider OwnershipINFUInfuSystem10.80%INGNInogen2.50%MYOMyomo12.14%STXSStereotaxis16.03%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINFUInfuSystem41020.18 million19.10 millionOptionableINGNInogen1,03027.08 million26.40 millionOptionableMYOMyomo9038.64 million33.95 millionNot OptionableSTXSStereotaxis13097.74 million82.07 millionNot OptionableMYO, INFU, INGN, and STXS HeadlinesRecent News About These CompaniesAnalysts See 124.7% Upside In Stereotaxis (STXS); Find Out WhyMay 24, 2026 | finance.yahoo.comStereotaxis Inc (STXS) Q1 2026 Earnings Call Highlights: Navigating Regulatory Wins and Revenue ...May 13, 2026 | finance.yahoo.comStereotaxis, Inc. (STXS) Q1 2026 Earnings Call TranscriptMay 12, 2026 | seekingalpha.comStereotaxis Inc. (STXS) Reports Q1 Loss, Lags Revenue EstimatesMay 12, 2026 | zacks.comStereotaxis Reports 2026 First Quarter Financial Results & Business UpdatesMay 12, 2026 | globenewswire.comWhy Stereotaxis (STXS) Could Be One of the Best Robotics Stocks to Buy Under $30May 2, 2026 | finance.yahoo.comStereotaxis stock up on first US MAGIC procedures post approvalApril 24, 2026 | msn.comStereotaxis Stock Up on First U.S. MAGiC Procedures Post ApprovalApril 23, 2026 | zacks.comStereotaxis reports first US procedures with MAGiC ablation catheterApril 22, 2026 | massdevice.comStereotaxis Announces First MAGiC Procedures in the United StatesApril 22, 2026 | globenewswire.comStereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026April 21, 2026 | globenewswire.comSTXS to Acquire Robocath to Lead in Endovascular Robotics MarketApril 17, 2026 | zacks.comAnalysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY) and Stereotaxis (STXS)April 16, 2026 | theglobeandmail.comRoth MKM Reaffirms Their Buy Rating on Stereotaxis (STXS)April 16, 2026 | theglobeandmail.comStereotaxis to acquire Robocath for up to $45MApril 16, 2026 | massdevice.comStereotaxis to acquire Robocath for $20M upfrontApril 16, 2026 | seekingalpha.comStereotaxis, Inc. (STXS) M&A Call TranscriptApril 15, 2026 | seekingalpha.comStereotaxis Announces Definitive Agreement to Acquire RobocathApril 15, 2026 | globenewswire.comStereotaxis Earnings Call: Growth Promise Amid StrainsApril 14, 2026 | theglobeandmail.comSTXS Gains on FDA Nod for Synchrony System, Expands Digital SurgeryApril 7, 2026 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMYO, INFU, INGN, and STXS Company DescriptionsInfuSystem NYSE:INFU$9.15 +0.07 (+0.77%) Closing price 06/24/2026 04:00 PM EasternExtended Trading$9.12 -0.04 (-0.38%) As of 06/24/2026 05:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.Inogen NASDAQ:INGN$6.76 +0.22 (+3.36%) Closing price 06/24/2026 04:00 PM EasternExtended Trading$6.75 -0.01 (-0.15%) As of 06:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.Myomo NYSEAMERICAN:MYO$1.18 -0.01 (-0.84%) Closing price 06/24/2026 04:10 PM EasternExtended Trading$1.19 +0.01 (+0.85%) As of 05:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.Stereotaxis NYSEAMERICAN:STXS$1.63 -0.12 (-6.86%) Closing price 06/24/2026 04:10 PM EasternExtended Trading$1.68 +0.05 (+3.25%) As of 04:44 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why KB Home Could Reward Patient Investors Later Tesla's New NHTSA Probe Lands at the Worst Possible Time Meta's Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time ASML’s Chip Dominance Runs Into New Silicon Boundaries Frozen Assets: How Super Micro Puts AI Heat on Ice The SpaceX Sell-Off May Be More Than a Market Overreaction Why These South Korea-Focused ETFs Have More Than Doubled in 2026 Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
